Cardiac magnetic resonance and cardio-oncology: Does T(2) signal the end of anthracycline cardiotoxicity? Editorial

   

Authors:	Yu, A. F.; Chan, A. T.; Steingart, R. M.
Title:	Cardiac magnetic resonance and cardio-oncology: Does T(2) signal the end of anthracycline cardiotoxicity?
Keywords:	doxorubicin; dose response; nonhuman; chemoprophylaxis; editorial; risk factor; risk assessment; diagnostic value; early diagnosis; cardiotoxicity; anthracycline derivative; echocardiography; anthracycline; heart left ventricle ejection fraction; beta adrenergic receptor blocking agent; dipeptidyl carboxypeptidase inhibitor; heart protection; angiotensin receptor antagonist; heart muscle fibrosis; multimodal imaging; razoxane; cardiovascular magnetic resonance; human; priority journal; cardio-oncology; cmr
Journal Title:	Journal of the American College of Cardiology
Volume:	73
Issue:	7
ISSN:	0735-1097
Publisher:	Elsevier Science, Inc.
Date Published:	2019-02-26
Start Page:	792
End Page:	794
Language:	English
DOI:	10.1016/j.jacc.2018.11.045
PUBMED:	30784672
PROVIDER:	scopus
PMCID:	PMC6544355
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061298583&doi=10.1016%2fj.jacc.2018.11.045&partnerID=40&md5=0367fda927de6774b0c62300fce3ed7a
Notes:	Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/142676